Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Endor Labs Receives Intellyx Digital Innovation Award

    May 25, 2023, 13:49 PM by
    Endor Labs, a startup securing open source software (OSS) and the supply chain, has received the Intellyx Digital Innovation Award, which recognizes technology providers who make it through the analyst firm’s rigorous briefing selection process – leading-edge vendors driving enterprise digital transformation.
    Full story
  • Debiopharm Partners with Genedata to Digitalize Translational Research

    May 25, 2023, 13:49 PM by
    Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy
    Full story
  • AI-Designed Cancer Drug from Insilico Medicine Receives FDA IND Approval to Advance to Clinical Trials

    May 25, 2023, 13:49 PM by
    Insilico Medicine, a leading company in the use of generative artificial intelligence (AI) for drug discovery and design, has announced that it has received investigational new drug (IND) approval from the FDA for its novel, small molecule inhibitor of USP1 to treat solid tumors. It's the first of Insilico's numerous AI-designed cancer drugs to advance to the clinical validation stage.
    Full story
  • Sustainable medicines packaging awards shortlist announced

    May 25, 2023, 13:49 PM by
    Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma
    Full story
  • For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions

    May 25, 2023, 13:49 PM by
    For Canadian Pharmacies, AI Conquers a Mountain of Faxed Prescriptions
    Full story
  • DNA Printing, Bioengineered Kidney Constructs in Space, Revvity’s Big Pharma Agreements, More

    May 24, 2023, 01:00 AM by User Not Found
    Bio-IT World | The Association for Molecular Pathology releases recommendations for germline variants detected by NGS, 10x Genomics wins German injunction against NanoString Technologies, and Revvity—formerly PerkinElmer—announces new license agreement with AstraZeneca. Plus new products and deployments from DNA Script, Thermo Fisher, Model N, GenScript, and more.
    Full story
  • Bryn Roberts on Data Citizenship, FAIR Culture, Data Models for the Long Term

    May 23, 2023, 13:04 PM by User Not Found
    Bio-IT World | Bryn Roberts has spent thirty years in informatics and data, most recently at Roche and before that at AstraZeneca. Now as Global Head of Data and Analytics at Roche Information Solutions, Roberts applies his career-long learnings to the current era of data in life sciences.
    Full story
  • Bio-IT World Community Names Five New ‘Best of Show’ Products

    May 19, 2023, 16:20 PM by User Not Found
    Bio-IT World | Earlier this week during the Bio-IT World Conference & Expo, Bio-IT World named five 2023 Best of Show Awards winners including new products from Data Cicada, Genomenon, GitHub, Monomer Bio, and Starfish Storage.
    Full story
  • Expert.ai Launches AI Platform for Life Sciences

    May 19, 2023, 14:01 PM by
    Expert.ai Platform for Life Sciences strengthens solutions and industry practice honed by expert.ai from real-world implementations with global organizations and scientific publishers such as Sanofi, New England Journal of Medicine, EBSCO, 3M Health, and INSERM. Our new Platform for Life Sciences has been chosen as a “Best of Show” finalist for 2023 Bio-IT Awards!
    Full story
  • Rhapsody Names New Chief Financial Officer

    May 19, 2023, 14:01 PM by
    Full story
  • New Partnership Established: Alfa Chemistry Adds 200,000+ Chemicals to Spaya Database

    May 19, 2023, 14:01 PM by
    Full story
  • Summary of Large-Scale RNA Synthesis Methods

    May 19, 2023, 14:00 PM by
    Full story
  • Speeding Up The Cancer Drug Discovery Process with Zebrafish Disease Models

    May 19, 2023, 14:00 PM by
    Full story
  • Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-powered Life Sciences Solutions

    May 19, 2023, 14:00 PM by
    Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud’s Multiomics Suite, accelerating the research of life science companies and academic institutions. In addition, Form Bio has been designated by Google as a Google Cloud Premier partner.
    Full story
  • Inizio Targets Innovation and AI-Led Growth with Two Top Appointments

    May 19, 2023, 14:00 PM by
    Global strategic advisory agency Inizio has announced two senior leadership appointments to its Inizio Medical division, strengthening the AI and innovation capabilities of the business.
    Full story
  • Prescription Screening Process Analysis Provides New Possibilities for Pharmaceutical Industry

    May 19, 2023, 14:00 PM by
    Full story
  • CD Genomics Unveils Cutting-Edge Long-Read Metagenomic Sequencing Service

    May 19, 2023, 14:00 PM by
    Full story
  • CD Genomics Expands Services with Pre-made Library Sequencing for High-Throughput Analysis

    May 19, 2023, 14:00 PM by
    Full story
  • CD Genomics Harnesses Single-cell DNA Methylation Sequencing Service to Drive Scientific Breakthroughs

    May 19, 2023, 14:00 PM by
    Full story
  • The Next Era of AI Drug Discovery? Quantum Computing

    May 19, 2023, 14:00 PM by
    A consortium of international scientists has taken the first step toward incorporating quantum computing into AI-powered drug discovery.
    Full story
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy